The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response
- PMID: 8642301
- PMCID: PMC2192367
- DOI: 10.1084/jem.183.3.979
The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response
Abstract
Recent in vitro studies have established that activated B cells express OX40 ligand (L), a member of the tumor necrosis factor/nerve growth factor family of cytokines, and become stimulated to proliferate and secrete immunoglobulin (Ig) after cross-linking of OX40L by its counterreceptor OX40, which is expressed on activated T cells. In the present study we investigated the in vivo role of this receptor-ligand pair for the interaction of T and B cells in the course of the T-dependent B cell response against 2,4,6 trinitro-phenyl-keyhole limpet hemocyanin. First, we showed that OX40 is maximally expressed by T cells in the periarteriolar lymphoid sheath (PALS) 3 d after primary immunization. These OX40+ cells are located in close proximity to antigen-specific, activated B cells. Second, we demonstrated that blocking of OX40-OX40L interaction with polyclonal anti-OX40 antibody or with antibodies against certain peptide sequences within its extracellular domain resulted in a profound decrease of the anti-hapten IgG response, whereas the antihapten IgM response was grossly unchanged. Third, we showed that this antibody treatment leads to an inhibition of the development of PALS-associated B cell foci, whereas the formation of germinal centers remained intact. Finally, our data suggest that, whereas B cell memory development was not impaired by anti-OX40 administration, OX40-OX40L interaction seems to be crucial in the secondary immune response. We conclude from these data that the OX40-OX40L interaction in vivo is necessary for the differentiation of activated B cells into highly Ig-producing cells, but is not involved in other pathways of antigen-driven B cell differentiation such as memory cell development in the germinal centers.
Similar articles
-
Constitutive OX40/OX40 ligand interaction induces autoimmune-like diseases.J Immunol. 2002 Oct 15;169(8):4628-36. doi: 10.4049/jimmunol.169.8.4628. J Immunol. 2002. PMID: 12370402
-
CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.J Immunol. 1999 Jun 15;162(12):7058-66. J Immunol. 1999. PMID: 10358148
-
Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis.J Exp Med. 2000 Jan 17;191(2):375-80. doi: 10.1084/jem.191.2.375. J Exp Med. 2000. PMID: 10637281 Free PMC article.
-
OX40: targeted immunotherapy--implications for tempering autoimmunity and enhancing vaccines.Trends Immunol. 2002 Feb;23(2):102-9. doi: 10.1016/s1471-4906(01)02127-5. Trends Immunol. 2002. PMID: 11929124 Review.
-
OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology.Adv Immunol. 2010;105:63-98. doi: 10.1016/S0065-2776(10)05003-0. Adv Immunol. 2010. PMID: 20510730 Review.
Cited by
-
Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease.Gut. 1999 Dec;45(6):856-63. doi: 10.1136/gut.45.6.856. Gut. 1999. PMID: 10562584 Free PMC article.
-
TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand.J Exp Med. 2005 Nov 7;202(9):1213-23. doi: 10.1084/jem.20051135. J Exp Med. 2005. PMID: 16275760 Free PMC article.
-
Multiple effects of CD40-CD40L axis in immunity against infection and cancer.Immunotargets Ther. 2018 Jun 28;7:55-61. doi: 10.2147/ITT.S163614. eCollection 2018. Immunotargets Ther. 2018. PMID: 29988701 Free PMC article. Review.
-
The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice.J Immunol. 2017 Aug 15;199(4):1238-1249. doi: 10.4049/jimmunol.1700608. Epub 2017 Jul 10. J Immunol. 2017. PMID: 28696253 Free PMC article.
-
Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand.J Exp Med. 2000 Jan 17;191(2):365-74. doi: 10.1084/jem.191.2.365. J Exp Med. 2000. PMID: 10637280 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources